NanJing Pharmaceutical Co Ltd
SSE:600713
Wall Street
Price Targets
Price Targets Summary
NanJing Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
NanJing Pharmaceutical Co Ltd
is 11.6 CNY
.
Operating Income
Forecast
Operating Income Estimate
NanJing Pharmaceutical Co Ltd
For the last 8 years the
compound annual growth rate for
NanJing Pharmaceutical Co Ltd's operating income is
16%.
The projected
CAGR
for the next 7 years is
-18%.
Net Income
Forecast
Net Income Estimate
NanJing Pharmaceutical Co Ltd
For the last 8 years the
compound annual growth rate for
NanJing Pharmaceutical Co Ltd's net income is
21%.
The projected
CAGR
for the next 5 years is
-13%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NanJing Pharmaceutical Co Ltd's stock price target?
Price Target
11.6
CNY
According to Wall Street analysts, the average 1-year price target for
NanJing Pharmaceutical Co Ltd
is 11.6 CNY
.
What is NanJing Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-10%
For the last 8 years the
compound annual growth rate for
NanJing Pharmaceutical Co Ltd's revenue is
11%.
The projected
CAGR
for the next 5 years is
-10%.
What is NanJing Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-18%
For the last 8 years the
compound annual growth rate for
NanJing Pharmaceutical Co Ltd's operating income is
16%.
The projected
CAGR
for the next 7 years is
-18%.
What is NanJing Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-13%
For the last 8 years the
compound annual growth rate for
NanJing Pharmaceutical Co Ltd's net income is
21%.
The projected
CAGR
for the next 5 years is
-13%.
You don't have any saved screeners yet
